Crossmark

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients

Crossref DOI link: https://doi.org/10.1186/s12890-019-0780-3

Published Online: 2019-01-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ravaglia, Claudia http://orcid.org/0000-0002-2975-7299
Wells, Athol U.

Tomassetti, Sara

Gurioli, Carlo

Gurioli, Christian

Dubini, Alessandra

Cavazza, Alberto

Colby, Thomas V.

Piciucchi, Sara

Puglisi, Silvia

Bosi, Marcello

Poletti, Venerino
License Information

Text and Data Mining valid from 2019-01-16
More Information

Article History

Received: 11 September 2018

Accepted: 7 January 2019

First Online: 16 January 2019

Ethics approval and consent to participate

: This study was approved by the Area Vasta Romagna Ethical Committee and conducted in accordance with the amended Declaration of Helsinki; written informed consent has been obtained from all subjects prior to the procedure.

: Not applicable.

: VP has served as a paid consultant to Erbe, Germany; none of all others have any potential conflicts of interest with any companies/organizations whose products or services may be discussed in this paper.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.